Hemophilia B

Hemophilia B is the indication for 6 drugs in DrugBank. It is covered by 19 curated, structured indications.

Also known as: Hereditary factor IX deficiency · Haemophilia B · Christmas Disease · Hemophilia Bs · Bs, Hemophilia
Classified under: Cardiovascular Diseases
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Genetic Variation
Hemic and Lymphatic Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Albutrepenonacog alfa
Coagulation Factor IX (Recombinant)
Coagulation factor VIIa Recombinant Human
Concizumab
Etranacogene dezaparvovec
Factor IX Complex (Human)

Resolves to

Vocabularies

MeSHM0004363ICD-10D67SNOMED CT154817006MedDRA10008793UMLSC0008533

What you can answer from here — as of October 25, 2026

6Indicated drugsWith each drug's targets and mechanism

Listed above

19Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

197Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Hemophilia B share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.